crlx101
Showing 1 - 7 of 7
Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)
Terminated
- Metastatic Castration Resistant Prostate Cancer
- Prostate Neoplasms
- enzalutamide
- CRLX101
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 16, 2022
Solid Tumors Trial in Grand Rapids, Houston, San Antonio (CRLX101, Bevacizumab, mFOLFOX6)
Terminated
- Solid Tumors
- CRLX101
- +2 more
-
Grand Rapids, Michigan
- +2 more
May 26, 2020
NSCLC Trial in Russian Federation, Ukraine (CRLX101, Best Supportive Care)
Completed
- Non-Small Cell Lung Cancer
- CRLX101
- Best Supportive Care
-
Saransk, Republic Of Mordovia, Russian Federation
- +24 more
May 26, 2020
Metastatic Renal Cell Carcinoma Trial in Korea, Republic of, United States (CRLX101, Bevacizumab, Standard of Care (Investigator
Completed
- Metastatic Renal Cell Carcinoma
- CRLX101
- +2 more
-
La Jolla, California
- +42 more
May 26, 2020
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Boston (CRLX101)
Completed
- Ovarian Cancer
- +2 more
- CRLX101
-
Boston, Massachusetts
- +3 more
Jun 28, 2018